U.S. Rep. Greg Steube says President Donald Trump’s order to reschedule marijuana offers a window for Congress to pass his bill doing just that.
“President Trump is right. Now is the time to reclassify marijuana, and the Drug Enforcement Administration must open the door for scientific research into the plant’s medicinal value,” said Steube, a Bradenton Republican.
Trump’s order directs Attorney General Pam Bondi to “take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III” of the Controlled Substances Act.
Steube says his bill (HR 4963) offers a pathway to expedite that, as it would reschedule the drug from current Schedule I to Schedule III within 60 days after it is enacted.
“My Marijuana 1-to-3 Act will deliver exactly what President Trump has requested: legislation that moves marijuana from Schedule I to Schedule III under the Controlled Substances Act,” Steube said.
“This bill will create new opportunities for scientists and physicians to develop treatments and cures for pain and disease. I am grateful for the White House’s leadership on this issue and call on my colleagues in Congress to bring the Marijuana 1-to-3 Act to the House floor immediately.”
Schedule I includes hard drugs, such as “heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.”
Schedule III includes “drugs with a moderate to low potential for physical and psychological dependence” like “products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone.”
Steube has filed this bill for the last four years.
